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Abstract 
 
Due to its more and more limited availability, clean water is now recognized as a valuable resource 
and this has changed the way wastewater is viewed. Once seen as a problem to be dealt with it is 
now a potential auxiliary source of water, thanks to recent advances in water treatment technology, 
particularly tertiary treatment for water recycling. The discovery that natural and synthetic 
chemicals, in the form of excreted hormones and pharmaceuticals, as well as a vast array of 
compounds with domestic and industrial applications, can enter the environment via wastewater 
treatment plants and cause a wide variety of toxic effects, suggests the need for improvement of 
wastewater treatment. Very low concentrations of organic contaminants are reportedly hazardous to 
the environment. Three Australian wastewater recycling schemes, two of which employ reverse 
osmosis (RO) technology, the other applying ozonation and biological activated carbon filtration 
(BAC), have been studied for their ability to remove trace organic contaminants including eleven 
pharmaceutically active compounds and two non-steroidal estrogenic compounds. Contaminant 
concentrations were determined using a sensitive analytical method comprising solid phase 
extraction, derivatization and GC MS with selected ion monitoring. In raw wastewater, 
concentrations of analgesics and non-steroidal anti-inflammatory medications were comparable to 
those found in wastewaters around the world. Remarkably, removal efficiencies for the three 
schemes were superiour to literature values. RO was responsible for the greatest proportion of 
contaminant removal. The ability of the RO and microfiltration membranes to brine (concentrate) 
many of the compounds was demonstrated and highlights the need for continued research into 
monitoring wastewater treatment processes, improved water recycling schemes and ultimately, safer 
water and a cleaner environment. 
 
Key words: Wastewater recycling, Trace organic removal, brine and concentrate, reverse osmosis, 
ozonation, biological active carbon filtration 
 
 
 
 2 
1 Introduction  
 
Prolonged drought conditions and increased water consumption, especially in Australia, have forced 
water authorities, consumers and local councils to consider wastewater recycling as a 
supplementary water supply. Hence there is a growing momentum favoring reuse of wastewater as 
well as a strong resistance to current disposal methods that have been seen as both environmentally 
damaging and a waste of potentially valuable resources (Beder, 1989). 
However, some major wastewater treatment plants in Australia are still discharging primary 
effluents. In recent years, increasing pollution in the receiving waters and more stringent effluent 
limitations for discharges to sensitive zones have been the driving forces in implementing new 
treatment techniques. Targeted parameters - in addition to grit and suspended solids - are chemical 
oxygen demand (COD), biochemical oxygen demand (BOD), pH, total suspended solids (TSS), 
nutrients (nitrogen and phosphorus), cations, anions, heavy metals and priority pollutants. This new 
approach for wastewater management has greatly affected the concept of wastewater recycling and 
the quality of water produced may be suitable for a range of reuse applications. Work is in progress 
to determine tailored guidelines for different water reuse applications. 
The number of organic compounds that have been synthesized since the turn of the century now 
exceeds a half million, and some 10,000 new compounds are added each year. As a result, many of 
these compounds are now also found in the wastewater from most municipalities and communities. 
Different classes of trace contaminants have been detected such as surfactants (Birkett and Lester, 
2003, Paxéus, 1996), polycyclic aromatic hydrocarbons (PAHs) (Blanchard et al., 2001, Blanchard 
et al., 2004, Paxéus, 1996, Pham and Proulx, 1997), polychlorinated biphenyls (PCBs)(Blanchard et 
al., 2001, Blanchard et al., 2004, Paxéus et al., 1992, Pham and Proulx, 1997), persistent organic 
compounds (Katsoyiannis and Samara, 2004), phthalates (Fromme et al., 2002, Paxéus, 1996), non-
steroidal estrogenic compounds (nSECs),(Bendz et al., 2005, Birkett and Lester, 2003, Bolz et al., 
2000, Clara et al., 2005, Khan et al., 2005, Korner et al., 2000, Lee et al., 2004, Paxéus, 1996, Price 
et al., 2005, Sekela et al., 1999) steroid hormones (Khan, 2002, Khan et al., 2005, Price et al., 
2005), pharmaceutically active compounds (PhACs) (Bendz et al., 2005, Blanchard et al., 2004, 
Carballa et al., 2004, Clara et al., 2005, Granier et al., 1988, Joss et al., 2005, Khan, 2002, 
Koutsouba et al., 2003, Lindqvist et al., 2005, Loraine and Pettigrove, 2006, Macia' et al., 2004, 
Pham and Proulx, 1997, Price et al., 2005, Stumpf et al., 1999, Ternes, 1998, Vieno et al., 2005) 
and pesticides (Dewedar et al., 1995, Katsoyiannis and Samara, 2004, Singh et al., 2004, Van der 
Bruggen et al., 1998).  
Most pharmaceuticals (if not all) administrated to humans and animals are partially excreted and 
discharged directly to the sewage system depending upon the physiochemical properties of the 
compounds. Investigations carried out in Austria, Brazil, Canada, Croatia, England, Germany, 
Greece, Italy, Spain, Switzerland, the Netherlands and the United States detected more than 80 
pharmaceuticals and their metabolites in the aquatic environment at concentrations in the µg/L 
range or lower (Herberer, 2002). Reported compounds include pharmaceuticals with a wide range 
of applications: analgesics, anti-inflammatory compounds, beta-blocker, lipid regulators, 
antiepileptic, antibiotics, X-ray media contrast agents and contraceptive drugs (Herberer, 2002, 
Khan, 2002). Carballa et al, (Carballa et al., 2004) have studied the presence of 13 pharmaceutical 
and personal care products (PPCPs) corresponding to different kinds of substances (artificial masks, 
pharmaceuticals and hormones) as an indicator of the presence of this type of pollution in the 
municipal wastewater generated by Galicia City (NW Spain). Eight compounds were detected in 
raw wastewater (galaxolide, tonalide, ibuprofen, naproxen, sulfamethoxazole and iopromide). All 
these compounds were present in the range of 0.6 to 6.6µg/L. 
The overall removal efficiencies within the sewage treatment plant (STP) of Galicia City were 
between 40 to 90% (Carballa et al., 2004). The detection of PhACs has also been reported in ground 
water contaminated by landfill leachate or manufacturing residues. Rarely, PhACs have also been 
detected in drinking water samples (Herberer, 2002). 
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Non-steroidal estrogenic compounds (nSECs), of which bisphenol A (BPA) is one of the most 
predominant examples and is manufactured in large quantities with over 90% being used in the 
plastic industry for the production of polycarbonate and epoxy resins, unsaturated polyester-styrene 
resin and flame retardants. Because BPA is used widely in households and industry, it is expected to 
be present in raw sewage, wastewater effluents, and in sewage sludge.  Formme et al., (2002) found 
low concentrations of BPA in surface water (0.0005 to 0.41µg/L), sewage effluents (0.018 to 0.702 
µg/L), sediments (0.01 to 0.19 mg/L) and sewage sludge (0.004 to 1.363 mg/L).  
 
 Bergeron (1999) has reported the estrogenic activity of BPA, with potency orders of magnitude less 
than 17β-estradiol. Chen et al, (Chen et al., 2002) determined that other bisphenols used in 
industrial applications are also weakly estrogenic. 
 
Nonylphenol ethoxylates (NPhEO) are a group of nonionic surfactants which are used in household 
and industrial applications. Under anaerobic conditions, biodegradation of nonylphenol ethoxylates 
yields the more toxic 4-substituted monoalkylphenol (4-nonylphenol, NP) (Sekela et al., 1999). The 
estrogenic potencies of NP and its ethoxylates (NPEO) are in order of magnitude five to six times 
lower than 17-βestradiol. Levels of NPEO and NP in the United Kingdom range from <0.02 to 
53µg/L in surface water and from < 0.02 to 300µg/L in effluent concentrations from sewage 
treatment plants (STW) (Birkett and Lester, 2003).  
To place abundance of those compounds into perspective; Paxéus et al, (1992) found that the major 
organic components in the influent to wastewater treatment plants were long chain fatty acids and 
their esters mainly from soap, edible oils and fat. The second largest group were the washing and 
cleaning related products consisting of ethers of polyethylene glycol (PEG) and polypropylene 
glycol (PPG), alkylphenols and alkylphenol ethoxylates (APEOs) which originated from detergents 
(Eriksson et al., 2002, Paxéus, 1996, Paxéus and Schröder, 1996). 
 
The primary objective of this study is to investigate the occurrence of nSECs and PhACs 
throughout wastewater recycling schemes. Acetominophen, carbamazepin, clofibric acid, diclofenac 
sodium, gemfibrozil, ibuprofen, ketoprofen, naproxen, primidone, phenytoin and salicylic acid 
represent PhACs. BPA and NP represent nSECs. These compounds were selected based on 
previous detection in wastewater combined with anticipated health and environmental effects or 
bioaccumulation potential. This paper provides information that can be used for further research, in 
guiding regulatory providers and in designing further treatment schemes and monitoring programs. 
The results of this study will indicate the benefit of the technology implemented in wastewater 
recycling schemes. 
 
2 Wastewater Recycling Schemes 
2.1 Gerringong Gerroa Sewage Scheme (GGSS) 
Owned by Sydney Water and operated by General Water Australia, the Gerringong Gerroa 
Sewerage Scheme (GGSS) is located 120 km south of Sydney on the southeast coast of Australia, 
near the town of Kiama and is adjacent to the Crooked River. It serves a population of about 4000 
and receives domestic discharges. The average discharge volume is 0.7 ML/day and the surplus 
flows are discharged to sand dune systems. Once the sand dunes reach capacity, the excess is 
discharged to the Crooked River (Boake, 2006, Sydney Water, 2005). A minimum of 80% of 
treated wastewater is used by adjacent dairy farmers for pasture production that currently irrigates 
70 hectares (Radcliffe, 2004). 
The GGSS consists of screens, a biological reactor, clarifier, sand filtration, ozonation, biological 
activated carbon (BAC), microfiltration (MF), UV disinfection and chlorination (see Figure 1). 
Samples were taken in December 2005. 
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2.2 Water Reclamation and Management Scheme (WRAMS)  
The Water Reclamation and Management Scheme (WRAMS) is owned by Sydney Olympic Park 
Authority (SOPA).  WRAMS integrates sewage treatment and storm water collection. It serves the 
Olympic Park as well as the adjacent suburb of Newington through a dual reticulation system in 
which households are connected to a potable tap water as well as a recycled water supply. The 
treated wastewater is used for all non-drinking purposes by residents, commercial premises, sport 
venues, parklands and playing fields. WRAMS has capacity of 2.2ML/day and can treat up to 
7ML/day (Chapman, 2006).  
WRAMS consists of screen, grit removal, an activated sludge process, UV disinfection, 
microfiltration (MF), reverse osmosis (RO) and chlorination (see Figure 2). The MF back flush is 
sent to the brick pit for dilution while the RO brine is sent to the Sydney sewer. It should be noted 
that the RO is only used as for storm water treatment which is supplied via a brickpit. Sewage is 
treated by MF only as no salt removal is intended. Samples were taken in May 2005. 
2.3 Luggage Point Water Reclamation Plant (LPWRP) 
Brisbane Water has ten sewage treatment plants (STPs), from which it discharges 285 ML/day into 
the environment (adjacent to the environmentally sensitive Moreton Bay), 2 ML/day are used on 
golf courses and more than 10 ML/day are recycled through LPWRP. The LPWRP is located near 
the mouth of the Brisbane River. The LPWRP produces 8.8 ML/day of very high quality water and 
is capable of producing of 10.6 ML/day. The product water is delivered to the BP refinery (four km 
away) as cooling tower make up, boiler feed water and other process uses. LPWRP returns the 
rejects (MF back flush and RO brine) back to the head of the wastewater treatment plant. The reject 
flows are 30% or approximately 3.6 ML/day when the plant is producing 8.8 ML/day (Simpson, 
2006). The LPWRP consists of automatically backwashing 300 µm screens, microfiltration (MF) 
and reverses osmosis (RO) (see Figure 3). All wastewater is treated by RO in this case. Additional 
chemical treatment is used to adjust water pH and chlorination. Samples were taken in September 
2005. 
 
 
3 Materials and Methods 
3.1 Chemicals 
Standards of carbamazepine, clofibric acid, ibuprofen, ketoprofen, diclofenac sodium, naproxen, 
primidone, gemfibrozil, bisphenol A, 4-nonylphenol, salicylic acid, acetaminophen and phenytoin 
were all purchased from Sigma–Aldrich, Australia. Carbamazepine-d10, 2-hydroxybenzoic acid-d6, 
gemfibrozil-d6, (+/-) –ibuprofen-d3, 5,5,’ phenytoin-d10, and 4-n-nonylphenol 2,3,5,6-d6,O,D were 
purchased from Scientific Technology, Australia.  
  
3.2 Sampling and sample preparation 
Composite raw wastewater samples and grab samples from the feed and effluent of the various unit 
operations were taken at each scheme. Sampling points are shown in Figure 1 to Figure 3. All 
samples were collected in 2.5 L amber glass bottles, transferred overnight and processed 
immediately. 
Upon receipt in the laboratory each sample was filtered using three different filters, GF/D (2.7µm) 
and GF/F (0.7µm) Whatman filters and 0.48 µm Nylon filter membrane (Alltech, Australia).  
Filtered samples were kept in the amber bottle overnight at 4 oC and sample enrichment was carried 
out the next day. Before sample enrichment, water samples of one liter were allowed to reach room 
temperature and the pH was adjusted to pH 2-3 to enhance trapping of the acidic compounds on the 
solid phase extraction (SPE) sorbent. Finally, the wastewater samples were spiked with a mixture of 
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the deuterated internal standards for analyte quantitation. MilliQ water (1 L) was also spiked with a 
standard mixture of the investigated compounds to confirm recovery of analytes.  
For solid phase extraction (SPE), 60mg Water Oasis HLB sorbent cartridges (Waters, Australia) 
were used. SPE was performed using a 24 fold extraction manifold (Supelco Visiprep 24). The SPE 
cartridges were conditioned sequentially with 5 mL methyl tetra butyl ether (MTBE), 5mL 
methanol and 5 mL MilliQ water. Extraction of the 1L sample was carried out under vacuum at a 
flow rate of approximately 15 mL/min. After sample loading the cartridge was washed with 3 mL 
5% methanol in water (v/v). In order to eliminate the presence of water from the eluate, a column of 
anhydrous sodium sulfate was prepared and fitted under the SPE column before the elution 
procedure started. The SPE columns were eluted with 5 mL 10% methanol in MTBE (v/v). The 
elution volume was then evaporated to dryness at 39 oC under a stream of nitrogen
.  
 
 
To determine PhACs and nSECs concentrations, a derivatization step was necessary. The extract 
residues were dissolved in 300 µL of acetonitrile and then derivatized by adding 100 µL of BSTFA 
and TMCS (99:1). The analytes were allowed to react for 1h at 70 oC. Finally, 100 µL of fluazifop 
standards were added to each vial before injection as an instrument internal standard to confirm 
injection of each sample onto the GC column.  
 
3.3 Identification and quantification of compounds 
A Shimadzu-GC 17A gas chromatograph was used, equipped with an auto-injector model AOC-20i, 
mass detector model QP5000, Phenomenex Zebron ZB-5 column and Split / Splitless injector. The 
oven temperature program was 100 oC (0 min); 30 oC/min.; 150 oC (4 min); 3 oC /min; 195 oC (0 
min.); 1 oC/min; 205 oC (5 min); 30 oC/min; 250 oC (3 min). The injection temperature was held at 
270 oC. Helium was used as a carrier gas (flow rate 1 mL/min) and the interface temperature was 
held at 270 oC. For identification of each analyte, three compound specific ions were recorded in the 
SIM mode. Analytes were identified positively in case identical retention time and mass ratios 
similar to the mass ratio retrieved through calibration were obtained.  
 
Deuterated standards were used as internal standard for quantitation of PhACs and nSECs (1ng/L). 
Calibration curves for PhACs and nSECs were found to be linear within the 5.0 to 0.1 ng/µL range. 
Minimum detection limits (MDLs) were 0.01µg/L for all analytes. 
3.4 Determination of the concentration factor in reverse osmosis 
The concentration factor is a ratio of the concentration of a component in the brine compared to the 
influent (feed), which depends on the recovery of water and retention of individual compounds. 
Retention is dependant on many factors such as the chemical characteristics of compounds, 
membrane characteristics, water matrix and adsorption interactions between compounds and 
membrane (Van der Bruggen et al., 2003).  
The membrane recovery (r) and retention (or rejection) (Ret) are defined in equations (1) and (2), 
respectively. 
 
FQ
Q
r
p
=
   (1) 
F
P
C
C1Ret −=    (2) 
The flow and mass balances are defined in equations (3) and (4). 
CPFQ QQ +=     (3) 
CCPPFF QCQCQC +=    (4) 
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Where: QP, QF  and Qc are the permeate, feed and brine flow (L/h), respectively. Likewise, 
CP, CF and CC are the permeate, feed and brine concentration (mg/L).  
Combining the mass and flow balance in equations (3) and (4) with retention in equation (2) and 
recovery in equation (1) yields the concentration of solutes in the RO brine. 
( )




−
−−
=
r
rCC
1
Rej11
FC     (5) 
Dividing the concentration of solutes in the brine from equation (5) by the concentration of solute in 
the feed results in the concentration factor shown in equation (6) 
FC
CF C=      (6) 
 
3.5 Determination of other Chemical Parameters 
Each sample collected from GGSS and LPWRP was characterized chemically by measuring pH, 
conductivity, absorbance at 245 nm, turbidity, total organic carbon (TOC, measured as non 
purgeable carbon (NPOC)) and total nitrogen (TN) in the laboratory. 
TOC and TN were measured using Shimadzu model TOC- Vcsh equipped with the total nitrogen 
analyzer TNM-1. Other parameters such as pH, turbidity, absorbance and conductivity were 
determined using standard laboratory equipment.  
Total solids (TS), total suspended solids (TSS), chemical oxygen demand (COD) and nutrient 
contents for the influent and effluents were provided by the scheme authorities as required.  
 
4 Results and Discussion 
The abundance of trace contaminants in water recycling schemes is of interest for a number of 
reasons. Firstly, the concentration in the product water has to date attracted the most attention due to 
the need for safety of the water, particularly if it is intended for human contact or even consumption 
(Higgins et al., 2002). However, low contaminant concentrations resulting from advanced 
technology, such as ozonation and reverse osmosis, combined with low consumption of water, 
means that this is unlikely to be a problem, with the exception of failures such as the desorption of 
adsorbed contaminants (Nghiem and Schäfer, 2006). Secondly, skin contact and occupational health 
and safety of workers may be of concern. Little work is available on the human health risks of 
handling contaminants in recycled wastewater. This study aims to provide important data in terms 
of concentrations to be expected in different process streams.  
Thirdly, and probably most crucially, discharge of partially treated wastewater, backwash waters 
and brines inland or into sensitive marine environments is a major concern. Further, this 
environmental health hazard may translate into a human health risk if compounds are accumulated 
or concentrated in seafood. In this research the concentration of compounds in process streams 
including microfiltration backwash water and reverse osmosis brines will be reported.  
4.1 Physicochemical Characteristics 
The physicochemical characteristics provided by the scheme operators for the influent and effluent 
steams reveal which parameters are parts of the continuous plant monitoring process (see Table 2). 
Results and monitored parameters vary between schemes. The most important learning from these 
results is that currently monitoring of recycling schemes is minimal. The majority of providers of 
recycled water monitor the quality parameters specified by EPA licenses. Higgins et al.,  (2002) 
found that less than 10% of users and providers of recycled water monitor components other than 
those required for the license compliance such as cations, sulphate, bicarbonate, alkalinity, turbidity 
and chlorine (Higgins et al., 2002). However, most current wastewater discharge and reuse 
guidelines are limited to bulk parameters. Specific organic contaminants are to date not regulated in 
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Australia and monitoring is hence neither economic nor enforced. Research and development 
support for companies and monitoring of the performance of the key contaminants would in all 
likelihood provide great insight for the operation. It should be noted here that the RO permeate and 
brine data has been analyzed on request for this research. In terms of organic content (COD) and 
total dissolved solids (TDS), RO is the superior treatment as expected from previous research. 
To understand performance of the scheme in more detail, a small number of analyses were carried 
out in the laboratory. These parameters are pH, conductivity, turbidity, total organic carbon (TOC), 
absorbance at 245 nm and total nitrogen (see Figure 4). pH was observed to fluctuate between pH 6 
and 9. 
In GGSS, the trend of water quality is generally increasing during treatment. A dramatic decrease in 
turbidity, conductivity, absorbance, total nitrogen and organic carbon occurred after clarification 
and a significant further drop in turbidity occurred after BAC, however, beyond this treatment no 
further decrease in values for any of those parameters was detected (Figure 4).  
In LPWRP the trend is also one of increased water quality. All parameter values dropped post 
activated sludge and further reductions were found for all parameters except absorbance after RO 
(Figure 4). The final water quality was superior with regards to organic carbon and conductivity 
which was evident from COD and TDS. Unfortunately, there is an obvious production of waste 
streams such as the MF backwash water (high turbidity, TOC, TN and absorbance) as well as the 
RO brine (elevated conductivity, organic carbon, absorbance and TN). 
4.2 Trace Contaminants in Raw Wastewaters 
The raw wastewater results for the GGSS samples show surprisingly little in the way of PhACs, 
compromising low concentrations of ibuprofen (0.7 µg/L), ketoprofen (0.2 µg/L) and gemfibrozil 
(0.05 µg/L) only (see Figure 5) . These results may be explained by the small population (4000) and 
the possible dilution of domestic sewage with other waste streams entering the system. The 
presence of ibuprofen and ketoprofen (non-steroidal anti-inflammatory) and gemfibrozil (blood 
lipid regulator) could reflect the older population living in the Gerringong and Gerroa area. 
The results in the LPWRP and WRAMS show a high concentration of four different compounds 
namely salicylic acid (38.8 and 9.0 µg/L), acetaminophen (8.1 and 23.3 µg/L), ibuprofen (10.3 and 
2.8 µg/L), and naproxen (7.8 and 3.1 µg/L), respectively (Figure 5). The first two compounds are 
analgesics and the second are from the non steroidal anti-inflammatory group. Generally, these 
results are comparable with published data for cities with large populations where there is a high 
consumption of over the counter pain relief medication, but more specifically, salicylic acid (38.5 
µg/L) and naproxen (7.8 µg/L) are found at the highest published concentrations. Ibuprofen is 
determined in the intermediate range, acetaminophen falls in the lower range, while all other 
compounds tested were either not detected or detected at concentrations below those found 
elsewhere (Table 1). Bisphenol A was detected at high concentrations in the LPWRP, where local 
industry may have contributed, compared to the other two schemes.  
Compounds not detected in the raw wastewater may have been present at concentrations lower than 
the detection limit. 
4.3 Trace Organics Removal in Microfiltration (MF) 
The contaminant concentrations in the influent, effluent and back flush reject of the MF for LPWRP 
and WRAMS show that the MF did not contribute to the removal of these compounds (Figure 5). 
Concentrations were at or below the detection limits in the influent, effluent and backwash water. 
These results agree with another study where only partial reduction in pharmaceuticals 
concentrations was demonstrated (Khan et al., 2004). For GGSS, all organic contaminants were 
removed to below detection limits prior to MF and so a comparison with the other schemes could 
not be made. Furthermore, MF backwash water was not accessible for sampling so potential 
concentration of contaminants could not be determined. 
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4.4 Trace Organics Removal in Reverse Osmosis (RO) 
A comparison of the results obtained from the influent, effluent and the brine of the RO revealed 
that RO was the most effective treatment in removing the PhACs and nSECs even at influent 
concentrations below detection limits. RO brines may contain the highest concentrations if 
compounds are retained. These results agree with studies of other contaminated waters (Adams et 
al., 2002, Drewes et al., 2002, Heberer et al., 2002, Khan et al., 2004). RO membranes may further 
serve as a large reservoir for the PhACs and nSECs and their release is likely in the brine or during 
membrane cleaning processes. Treatment strategies for the brine and the spent solution need to be 
considered particularly when organic trace contaminants are of concern (Nghiem and Schäfer, 
2006). Results of RO for WRAMS are inconclusive. It should be noted here that the RO was not 
fully operational during this sampling exercise and that when operation is resumed confirmatory 
data will be obtained. It should be noted here however, that trace organics from municipal effluents 
are not targeted in this scheme as municipal effluent is treated only with MF, not RO. 
4.5 Concentration of Trace Organics in Reverse Osmosis (RO) 
In light of the interest in the RO brine concentrations, the likely concentration factor of trace 
contaminants in the reverse osmosis process has been calculated. Figure 6 shows concentration 
factor as a function of recovery and retention. A water recycling plant RO is usually operated at a 
recovery between 80 to 95% and the retention of trace organics varies from 0 to 100%. Retention is 
dependant on many factors such as the chemical characteristics of compounds, membrane 
characteristics, water matrix and adsorption interactions between compounds and the membrane 
(Agenson et al., 2003). 
A maximum concentration factor of 40 times can hence be expected if a compound is fully retained 
and system recovery is high. A comparison between the mathematical model and actual results 
showed that diclofenac, naproxen, ketoprofen, carbamazepine & phenytoin have a concentration 
factor 10-20 while primidone, acetaminophen and bisphenol A have a concentration factor 3-9. 
While results are in the right order of magnitude, losses are likely to occur on the membranes, in 
sample analysis and  incomplete retention (where levels are below the detection limit but volumes 
are high). 
4.6 Comparison of Trace Organic Removal in Water Recycling Schemes 
When comparing the product waters of the three schemes, the concentrations of the trace 
contaminants were lower than the detection limits for most of the compounds except for ketoprofen 
(0.11 µg/L), primidone (0.05 µg/L) and naproxen (0.03 µg/L) in the LPWRP. This is consistent with 
previous reports by Ternes (1998) that diclofenac, ibuprofen, indometacine, naproxen, ketoprofen 
and phenazone were present in more than 50% of the investigated STP discharge and the 90 
percentile concentration of diclofenac and ibuprofen exceeded 1 µg/L. Salicylic acid and 
acetaminophen were detectable only in some STP effluents. They are known to be entirely degraded 
in sewage treatment plants (Ternes, 1998).  
The removal efficiencies of PhACs and nSECs in the three schemes were determined by comparing 
the results of the raw wastewater and the recycled water. The removal rates of these compounds 
during passage through the different processes were higher than 90% for all compounds except for 
ketoprofen (80%). Despite the high concentrations in the raw wastewater, their removal was high in 
the treatment processes.  In this study, the removal efficiencies are superior to literature values. For 
ibuprofen, naproxen, ketoprofen and diclofenac previously reported removal rates were 75 to 100%, 
55 to 98%, 23 to 100% and 3 to 75%, respectively (Heberer et al., 2002, Lindqvist et al., 2005, 
Soulet et al., 2002, Stumpf et al., 1999, Ternes, 1998). The main reasons for variation are reported 
to be different treatment processes and variation in the functioning of the process (Soulet et al., 
2002, Tixier et al., 2003). The hybrid processes ozonation and BAC as well as the MF and RO to 
treat municipal wastewater is applying the most advanced technology available. The water quality 
Al-Rifai, J. ; Gabelish, C.L. ; Schäfer, A.I. (2007) Occurrence of pharmaceutically active and non-steroidal estrogenic compounds in three different wastewater recycling schemes in Australia, Chemosphere, 69, 803-815. 
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produced is excellent and potentially too good for irrigation. The use of MF for water recycling 
produces a product of clearly lower quality. 
These results indicate no doubt the effectiveness of advanced and more recently implemented 
technology in the different schemes such as ozonation, biological activated carbon, membranes and 
UV disinfection in the removal of trace contaminants. These results comply with studies that found 
the majority of the influent load was removed during secondary treatment;  51 to 99% yielding 
expected surface water concentrations of 0.013 to 0.056 µg/L (Thomas and Foster, 2005) and 55 to 
99% yielding 0.01 to 17.3 µg/L in the sewage effluent (Lee et al., 2004). 
The specific mechanisms responsible for this elimination of these compounds, which could be 
abiotic degradation induced by solar irradiation, biotransformation, physical sequestration or a 
combination of these, remains to be elucidated (Bendz et al., 2005, Sekela et al., 1999). 
 
5 Conclusions 
Three wastewater treatment plants have been analyzed for the presence of eleven pharmaceuticals 
and two non-steroidal estrogenic compounds, most of which have been detected in the influent of 
the three studied schemes. Some compounds were detected in other process streams such as MF 
backflush or RO brine which is indicative of an effective retention process but also demonstrates 
the creation of a new disposal problem. While the data is preliminary and requires confirmation 
with a longer term study, the presence of many trace organic compounds at substantial 
concentrations has been confirmed. Further work is required to determine the human and 
environmental health effects of those compounds in comparison with other exposure routes such as 
food residues. 
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Figure Captions 
 
Figure 1 Schematic of the Gerringong Gerroa Sewerage Scheme (GGSS) and sampling points used 
for this study. 
 
Figure 2 Schematic of the Water Reclamation and Management Scheme (WRAMS) and sampling 
points used for this study  
 
Figure 3 Schematic of the Luggage Point Water Reclamation Plant (LPWRP) and sampling points 
used for this study. 
 
Figure 4 Wastewater characteristics total organic carbon (TOC, measured as non purgeable organi 
carbon (NPOC)), turbidity, total nitrogen (TN), absorbance and conductivity of samples collected 
from GGSS (A) and LPWRP (B). 
 
Figure 5 Concentrations of PhACs and nSECs in GGSS (A), WRAMS (B) and LPWRP (C). 
 
Figure 6 Effect of recovery and retention on the concentration of compounds in the RO brine.  
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Table 1 Pharmaceutically Active Compounds (PhACs) and reported levels in the literature ( 
* Degradation products, (1) (Pham and Proulx, 1997),  (2) (Blanchard et al., 2004), (3) (Granier 
et al., 1988), (4) (Price et al., 2005), (5) (Khan, 2002), (6) (Carballa et al., 2004), (7) (Paxéus, 
1996), (8) (Buser et al., 1999), (9) (Soulet et al., 2002), (10) (Lee et al., 2004), (11)(Ternes, 
1998), (12)(Koutsouba et al., 2003), (13)(Clara et al., 2005), (14) (Joss et al., 2005), (15) (Stumpf 
et al., 1999), (16) (Macia' et al., 2004), (17) (Heberer et al., 1995), (18) (Bolz et al., 2000), (19) 
(Korner et al., 2000), (20) (Sekela et al., 1999), (21) (Dewedar et al., 1995), (22)  (Vieno et al., 
2005), (23) (Bendz et al., 2005), (24)(Lindqvist et al., 2005), (25)(Loraine and Pettigrove, 2006) 
 
PhACs  Reported concentrations in wastewater (µg/L) 
Analgesics and anti-inflammatory 
compounds 
 
Acetaminophen (Paracetamol) 10(1), 26(1) , 148.1(2) , 291.9 (3), 2.52-7.83(4) 
Acetylsalicylic acid (ASA)(Aspirin) 0.22(1) , 54(1), 0.34(1), 13(1), 3.2(5), 11.39-14.93(5),  
8.88 (2),  16.08(3), 54 (11) 
Ortho-hydroxyhippuric acid* 6.8(1) 
Gentisic acid* 4.6(1) 
Phenazone 0.069-0.37(5) 
Propyphenazone 0.010(5) , 0.01-0.2(12),   
Non-steroidal anti-inflammatory 
compounds 
 
Diclofenac 3.02(1), 0.035-0.560(5), 0.28-2.24(5), 0.05-5.63(4), 0.09-
4.11(13), 0.01-0.56 (12), 1.0(14), 0.8(15), 0.16(23), <0.5-
0.5(24), 100-510 (9) 
Ibuprofen 2.31(2) , 3.58(3), 5.7(6), 0.37-2.84 (4), 1.2-2.68(13), 
1.1(14), 0.3(15) , 23.4 (22), 0.49 (23) , 10-19.7(24) , 0.99-
3.3 (8) , 108-990 (9), 3.23-25.8 (25) 
Ketoprofen 0.13(2), 0.36-0.61(4), 0.5(15), 2.9(22), 0.49(23), 1-3(24), 
80-270 (26) 
Naproxen 3.84(2) , 3.01(3), 5.7(6), 0.37-1.7(4), 1.0(14), 0.6(15), 0.51
(16) 
, 8.6( 22), , 3.65(23) , 3-8(24), 23.21(25) 
Mefenamic 190-1900 (9) 
Antibiotics/Bacteriostatics  
Penicillin G <0.025(5) 
Penicillin V <0.035(5) 
Sulfamethoxazole 0.58(6), 0.02(23), 
Trimetoprim 0.11-0.37(5) 
Anti-epileptics (Anti-convulsants)  
Carbamazepine 0.21-0.91(5), 0.26(2), 0.10(3), 0.01(4), 0.325-1.85(13), 
0.9(14), 1.68(23), 
Primidone < 0.10(4) 
Atenolol 0.03(23), 
Metoprolol 0.16(23), 
Propanolol 0.05(23), 
Beta-blockers (anti-drenergenics)  
Clofibric acid* 0.47-1.48(5) ,< 0.10(4), 1.0(15),  1.2(17), 10-170 (9) 
Gemfibrozil 1.50(2) , 3.00(3) , 0.12-1.0(4) , 0.3(15), 0.71(23),  
Bezafibrate  3.32(5) , 1.55-7.60(13), 1.2(15), 2.2(22), <0.5-0.1(24), 
Contrast media  
Iodenated Xray  130(1) 
Diatrizoate 3.3(5) 
 22 
PhACs  Reported concentrations in wastewater (µg/L) 
Iopamidol 4.3(5)  
Iopromide 7.5(5), 6.6(6), 0.026-3.84(13), 1.1(14),  
Iomeprol 1.6(5) 
Ioxithalamic acid 0.17(5) 
Iothalamic acid 0.18(5) 
Cytostatics (antineoplastic agents)  
Ifosfamide 0.029(5) 
Cyclophosphamide 0.143(5) 
Oral Contraception  
Diethylstilbestrol 0.043(5) 
Calcium-channel blocking agents  
Verapamil 0.050-0.068(5) 
Others  
Metadone 0.28(3), 0.06(2) 
Phenytoin 0.29(3), 0.18(2) 
Morphin 1.39(3), 0.52(2) 
Musk Fragrance  
Galaxolide  3.4(6) , 0.83-4.44(13), 1.0(14), 0.79(23), 
Tonalide  1.7(6), 0.21-1.10(13), 0.7(14), 
nESCs  
Bisphenol A < 0.03- 0.34(4) , 0.16-28.1(10), 0.72-2.38(13) , ,3.01(19),  
Nonylphenol 0.5-3(7), < 0.10-0.17(4), 28-16.7(10), 1.28-4.03(13),  
2.1-2.45(19) , 2.9(20) , 1.14(23), 
Nonylphenol ethoxylate NPEO1               
& NPEO2 
0.5-17(7), 31-868(10) , 0.60-7.30(13) , 
Octylphenol 1(7), 1.05(10),  0.44-0.68(13), 0.27(18), 0.18-0.32(19), 
Octylphenol ethoxylate OPEO1 
 & OPEO2 
2(7), 0.04-0.66(13),  
Octanoic acid, hexadecyl ester 5-28(7) 
Octanoic acid, octadecyl ester 2-5(7) 
Ethylene glygol monoleate 42(7) 
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Table 2 Characteristics of raw wastewater and product water of the three schemes  
(n.m.: not measured)  
 
Schemes GGSS WRAMS LPWRP  Characteristics 
 
 
Unit 
Raw 
wastewater 
Product 
water 
Raw 
wastewater 
Product 
water 
Raw 
wastewater 
Product 
water 
Sample ID 1 8 1 7 1 11 
pH  7.6 7.3 7.5 7.7 7.36 n.m. 
Alkalinity as CaCO3  mg/L 241 n.m. n.m. n.m. n.m. n.m. 
Conductivity at 25 OC µS/cm n.m. 564. n.m. 431 2398 n.m. 
Turbidity NTU n.m. n.m. n.m. 0.11 n.m. n.m. 
Solid Content  
Total Suspended Solids mg/L 248 2 200 < 2 261.5 n.m. 
Total Dissolved Solids mg/L n.m 311 350 n.m. n.m. n.m. 
Organic Content 
Biochemical Oxygen 
Demand (BOD5) 
mg/L 235 2 200 5 257.8 n.m. 
Chemical Oxygen 
Demand (COD) 
mg/L 525 10 470 57 583.3 n.m. 
Nutrients  
Nitrogen  
Total Nitrogen mg/L 53.5 0.79 40 5.7 n.m. 0.40 
Ammonia as N mg/L 41.5 0.01 30 2.9 36.5 <0.004 
Oxidized Nitrogen mg/L 0.01 n.m 9.7 n.m. n.m. n.m. 
Nitrate as N  mg/L n.m. n.m. 0.05 n.m. n.m. n.m. 
Nitrite as N mg/L n.m. n.m. 0.27 n.m n.m. n.m. 
Phosphorus      
Total Phosphorus mg/L 10.8 0.017 7.00 0.84 10.57 <0.010 
Anions & cations 
Aluminum  mg/L n.m. 0.13 n.m. n.m. 0.50 <0.005 
Calcium mg/L n.m. 98.5 n.m. n.m. 45.2 n.m. 
Chlorine (free residual) mg/L n.m. n.m. n.m. 0.15 n.m. 8.5 
Fluoride  n.m. n.m n.m. n.m. n.m. < 0.01 
Magnesium mg/L n.m. 18 n.m. n.m. 46.4 n.m. 
Potassium mg/L n.m. 85.8 n.m. n.m. 30.5 n.m. 
Sodium mg/L n.m. 368 n.m. n.m. 393.7 n.m. 
Sulphides  n.m. n.m. n.m. n.m. 6.8 n.m. 
Microorganisms     
Faecal Coliforms (MF) CFU/100mL n.m. 0 n.m. 0 n.m. n.m. 
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